Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus. (2022)
Attributed to:
A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13578-022-00809-3
PubMed Identifier: 35690803
Publication URI: http://europepmc.org/abstract/MED/35690803
Type: Journal Article/Review
Volume: 12
Parent Publication: Cell & bioscience
Issue: 1
ISSN: 2045-3701